TD's Schwab Investment to Contribute C$194 Million in Bank's 2Q
By Adriano Marchese
Toronto-Dominion Bank said Tuesday that it expects a lower contribution to its second fiscal quarter results from its investment in Charles Schwab.
The Canadian financial institution said that it expects Schwab's earnings for the first quarter of fiscal 2024--which ends in October--to translate into about 194 million Canadian dollars, or about $140.7 million, of reported equity in net income of an investment for TD's second quarter of fiscal 2024.
Last year at this time, Schwab reported a contribution of C$241 million.
TD received a roughly 13.5% stake in Schwab as part of Schwab's acquisition of TD Ameritrade.
On an adjusted basis--which excludes acquisition-related charges of approximately C$5 million after-tax and amortization of acquired intangibles of approximately C$30 million after-tax--net income of an investment will be approximately C$229 million.
TD said it expects to release its first-quarter financial results on May 23.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 16, 2024 07:12 ET (11:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track